1 Start 2 Complete

How did you hear about this Continuing Education program?

Is this your first time attending an AU-HSOP Continuing Education program, live or online?

Yes

No

Other...

Is this your first time attending an AU-HSOP Continuing Education program, live or online? Other...

Prior to this CE program, how knowledgeable were you about this topic?

Extremely knowledgeable

Somewhat knowledgeable

Familiar

Not knowledgeable at all

Did your knowledge increase as a result of this CE Program?

Yes

No

In your opinion, what percentage of your patients will benefit from your newly gained knowledge?

0%-25%

25%-50%

50%-75%

75%-100%

I don't know/ this is not applicable

Will your newly gained knowledge benefit your healthcare team as a whole?

Yes

No

Not Applicable

Dr. Sean Smithgall

	Strongly Agree	Agree	Neither Agree nor Disagree	Disagree	Strongly Disagree
Presentation was at the appropriate level	Presentation was at the appropriate level - Strongly Agree	Presentation was at the appropriate level - Agree	Presentation was at the appropriate level - Neither Agree nor Disagree	Presentation was at the appropriate level - Disagree	Presentation was at the appropriate level - Strongly Disagree
Presentation was based on evidence	Presentation was based on evidence - Strongly Agree	Presentation was based on evidence - Agree	Presentation was based on evidence - Neither Agree nor Disagree	Presentation was based on evidence - Disagree	Presentation was based on evidence - Strongly Disagree
Handout materials were organized and useful	Handout materials were organized and useful - Strongly Agree	Handout materials were organized and useful - Agree	Handout materials were organized and useful - Neither Agree nor Disagree	Handout materials were organized and useful - Disagree	Handout materials were organized and useful - Strongly Disagree
Speaker was excellent	Speaker was excellent - Strongly Agree	Speaker was excellent - Agree	Speaker was excellent - Neither Agree nor Disagree	Speaker was excellent - Disagree	Speaker was excellent - Strongly Disagree
Speaker was an effective teacher	Speaker was an effective teacher - Strongly Agree	Speaker was an effective teacher - Agree	Speaker was an effective teacher - Neither Agree nor Disagree	Speaker was an effective teacher - Disagree	Speaker was an effective teacher - Strongly Disagree
Speaker engaged the audience in learning	Speaker engaged the audience in learning - Strongly Agree	Speaker engaged the audience in learning - Agree	Speaker engaged the audience in learning - Neither Agree nor Disagree	Speaker engaged the audience in learning - Disagree	Speaker engaged the audience in learning - Strongly Disagree
Learning assessment questions were appropriate	Learning assessment questions were appropriate - Strongly Agree	Learning assessment questions were appropriate - Agree	Learning assessment questions were appropriate - Neither Agree nor Disagree	Learning assessment questions were appropriate - Disagree	Learning assessment questions were appropriate - Strongly Disagree
Content will have a positive impact on how I practice	Content will have a positive impact on how I practice - Strongly Agree	Content will have a positive impact on how I practice - Agree	Content will have a positive impact on how I practice - Neither Agree nor Disagree	Content will have a positive impact on how I practice - Disagree	Content will have a positive impact on how I practice - Strongly Disagree
The presentation was balanced and unbiased	The presentation was balanced and unbiased - Strongly Agree	The presentation was balanced and unbiased - Agree	The presentation was balanced and unbiased - Neither Agree nor Disagree	The presentation was balanced and unbiased - Disagree	The presentation was balanced and unbiased - Strongly Disagree

Dr. Sean Smithgall Would you agree that each of the following objectives were achieved by the completion of this program?

	Strongly Agree	Agree	Neither Agree nor Disagree	Disagree	Strongly Disagree	No Opportunities / Not Applicable
Identify medications that interact with aspirin therapy concerning efficacy and bleeding	Identify medications that interact with aspirin therapy concerning efficacy and bleeding - Strongly Agree	Identify medications that interact with aspirin therapy concerning efficacy and bleeding - Agree	Identify medications that interact with aspirin therapy concerning efficacy and bleeding - Neither Agree nor Disagree	Identify medications that interact with aspirin therapy concerning efficacy and bleeding - Disagree	Identify medications that interact with aspirin therapy concerning efficacy and bleeding - Strongly Disagree	Identify medications that interact with aspirin therapy concerning efficacy and bleeding - No Opportunities / Not Applicable
Describe the risks and benefits of aspirin therapy when used for primary prevention	Describe the risks and benefits of aspirin therapy when used for primary prevention - Strongly Agree	Describe the risks and benefits of aspirin therapy when used for primary prevention - Agree	Describe the risks and benefits of aspirin therapy when used for primary prevention - Neither Agree nor Disagree	Describe the risks and benefits of aspirin therapy when used for primary prevention - Disagree	Describe the risks and benefits of aspirin therapy when used for primary prevention - Strongly Disagree	Describe the risks and benefits of aspirin therapy when used for primary prevention - No Opportunities / Not Applicable
Summarize the evidence related to low-dose aspirin for primary prevention of cardiovascular and cancer related endpoints	Summarize the evidence related to low-dose aspirin for primary prevention of cardiovascular and cancer related endpoints - Strongly Agree	Summarize the evidence related to low-dose aspirin for primary prevention of cardiovascular and cancer related endpoints - Agree	Summarize the evidence related to low-dose aspirin for primary prevention of cardiovascular and cancer related endpoints - Neither Agree nor Disagree	Summarize the evidence related to low-dose aspirin for primary prevention of cardiovascular and cancer related endpoints - Disagree	Summarize the evidence related to low-dose aspirin for primary prevention of cardiovascular and cancer related endpoints - Strongly Disagree	Summarize the evidence related to low-dose aspirin for primary prevention of cardiovascular and cancer related endpoints - No Opportunities / Not Applicable
Determine when it is appropriate the START and STOP low-dose aspirin for primary prevention	Determine when it is appropriate the START and STOP low-dose aspirin for primary prevention - Strongly Agree	Determine when it is appropriate the START and STOP low-dose aspirin for primary prevention - Agree	Determine when it is appropriate the START and STOP low-dose aspirin for primary prevention - Neither Agree nor Disagree	Determine when it is appropriate the START and STOP low-dose aspirin for primary prevention - Disagree	Determine when it is appropriate the START and STOP low-dose aspirin for primary prevention - Strongly Disagree	Determine when it is appropriate the START and STOP low-dose aspirin for primary prevention - No Opportunities / Not Applicable

What are three aspects of this program you found most useful?

What are three aspects of this program you found least useful?

Please list any topics that you would like to see for future CE programs:

Please add any additional questions, comments, concerns and/or suggestions you may wish to share with us.

Leave this field blank